Related Experiment Videos
The dexamethasone suppression and metyrapone tests in depression
Psychiatry Research
|June 1, 1985
Summary
The dexamethasone suppression test (DST) and metyrapone test (MT) assess the hypothalamic-pituitary-adrenal (HPA) axis in depression. Abnormal DST results in patients with melancholia did not indicate uniform HPA axis disturbances, showing complex relationships between the tests.
Area of Science:
- Neuroendocrinology
- Psychiatry
Background:
- The hypothalamic-pituitary-adrenal (HPA) axis is frequently dysregulated in major depressive illness.
- The dexamethasone suppression test (DST) and metyrapone test (MT) are used to evaluate HPA axis integrity.
Purpose of the Study:
- To investigate the relationship between the DST and MT in patients with major depressive illness and melancholia.
- To explore the heterogeneity of HPA axis disturbances in depressed patients exhibiting abnormal DST results.
Main Methods:
- The DST and MT were administered to 28 patients diagnosed with major depressive illness and melancholia.
- Cortisol and cortexolone levels were measured post-administration of dexamethasone and metyrapone.
Main Results:
- Patients failing the DST showed higher post-MT cortexolone levels and cortexolone/cortisol ratios compared to DST suppressors.
- A wide variability in metyrapone test responses was observed among patients with abnormal DST results.
Conclusions:
- Failure to suppress cortisol after dexamethasone in depressed patients does not imply a homogeneous disturbance in the HPA axis.
- The relationship between DST and MT in melancholic depression is complex, suggesting diverse underlying HPA axis pathophysiology.